Do allergy medications cause weight gain? It is a question many people ask when starting treatment for hay fever, allergic rhinitis, or asthma. The answer depends largely on which type of medication you are taking. Oral corticosteroids such as prednisolone are well-established causes of weight gain, whilst older first-generation antihistamines like chlorphenamine may theoretically influence appetite through sedation. Second-generation antihistamines — including loratadine and fexofenadine — are generally considered unlikely to cause significant weight changes. This article reviews the evidence, explains the mechanisms involved, and offers practical guidance aligned with NHS, NICE, and MHRA recommendations.
Summary: Some allergy medications, particularly oral corticosteroids and older first-generation antihistamines, can contribute to weight gain, whilst modern second-generation antihistamines such as loratadine and fexofenadine are unlikely to cause significant weight changes.
- Oral corticosteroids (e.g. prednisolone) are the allergy-related medicines with the strongest, best-documented link to weight gain, fluid retention, and increased appetite.
- First-generation antihistamines (e.g. chlorphenamine, promethazine) may theoretically increase appetite by blocking H1 receptors in the hypothalamus and causing sedation, but weight gain is not listed as an established adverse effect in their UK SmPCs.
- Cyproheptadine has the clearest pharmacological link to appetite stimulation among antihistamines, but is rarely used for allergy management in the UK today.
- Second-generation antihistamines (cetirizine, loratadine, fexofenadine) do not list weight gain as a common adverse reaction in UK SmPCs; any effect, if present, is considered small and uncertain.
- Intranasal and inhaled corticosteroids at standard licensed doses are not typically associated with significant weight changes, though high-dose or prolonged use warrants clinical monitoring.
- NICE CKS guidance recommends intranasal corticosteroids as first-line for moderate-to-severe allergic rhinitis and non-sedating antihistamines for mild symptoms, both of which carry a lower risk of weight-related side effects than oral corticosteroids.
Table of Contents
- Which Allergy Medications Are Linked to Weight Gain
- How Antihistamines May Affect Appetite and Body Weight
- Reviewing the Evidence: What Clinical Research Shows
- Other Factors That Can Influence Weight During Allergy Treatment
- Talking to Your GP About Allergy Medication Side Effects
- Choosing the Right Allergy Treatment for Your Needs
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Which Allergy Medications Are Linked to Weight Gain
When considering whether allergy medications cause weight gain, it is important to distinguish between the different classes of medicines used to manage allergic conditions. The most commonly discussed are antihistamines, particularly first-generation antihistamines such as chlorphenamine (Piriton) and promethazine. These older agents are associated with sedation and, in some individuals, increased appetite; however, it is worth noting that UK Summary of Product Characteristics (SmPCs) for chlorphenamine and promethazine do not list weight gain as an established adverse effect. The antihistamine with the clearest and best-documented link to increased appetite and weight gain is cyproheptadine — an older H1 antihistamine that is rarely used for allergy management in the UK today.
Second-generation antihistamines — including cetirizine, loratadine, and fexofenadine — are generally considered less likely to cause weight-related side effects. Some observational research has suggested a possible association between cetirizine use and modest weight changes, but this is not reflected in UK SmPCs, and any such effect, if present, is likely to be small. The clinical significance remains uncertain and should not be overstated.
Corticosteroids represent another important category. Oral corticosteroids such as prednisolone, when used for severe allergic reactions or conditions such as allergic asthma, are well-established causes of weight gain, particularly with prolonged use. They promote fluid retention, increase appetite, and can alter fat distribution — effects that are clearly documented in the prednisolone SmPC and acknowledged in NHS guidance. Intranasal corticosteroids (for example, fluticasone propionate nasal spray) and inhaled corticosteroids used for asthma are absorbed systemically in much smaller amounts and are not typically associated with significant weight changes at standard licensed doses. However, at high doses or with prolonged use, some systemic absorption may occur and clinically relevant effects, though uncommon, cannot be entirely excluded; patients on long-term high-dose inhaled or intranasal steroids should be monitored as clinically indicated.
Montelukast, a leukotriene receptor antagonist sometimes prescribed for allergic rhinitis and asthma, does not have an established link to weight gain, consistent with its SmPC. Similarly, allergen immunotherapy (desensitisation treatment) is not known to directly affect body weight. Understanding which specific medication you are taking is therefore the essential first step in evaluating any potential weight-related concerns.
How Antihistamines May Affect Appetite and Body Weight
The mechanism by which first-generation antihistamines may potentially contribute to weight changes is primarily related to their action on histamine receptors in the brain. Histamine plays a role not only in allergic responses but also in appetite regulation and energy metabolism. It acts on H1 receptors in the hypothalamus — the brain region responsible for hunger and satiety signals — to suppress appetite. When antihistamines block these receptors, this appetite-suppressing effect may be reduced, potentially leading to increased food intake. This mechanism is best established for cyproheptadine, which is sometimes used clinically to stimulate appetite in specific medical contexts.
First-generation antihistamines such as chlorphenamine and promethazine are highly sedating due to their ability to cross the blood-brain barrier. This sedation can reduce physical activity levels, which over time may contribute to a positive energy balance. Fatigue and drowsiness are listed as common side effects in the SmPCs for these medicines, and patients who feel persistently tired may naturally become less active. Whether this translates into clinically meaningful weight gain in most individuals is not clearly established in UK product information.
Second-generation antihistamines are designed to be more selective and have a reduced ability to cross the blood-brain barrier, which is why they cause considerably less sedation — a difference reflected in comparative sedation data in the BNF and individual SmPCs. Cetirizine has a slightly higher reported incidence of somnolence than loratadine or fexofenadine according to SmPC data, which may theoretically influence activity levels, but any resulting effect on weight is uncertain and likely small if present at all.
It is important to emphasise that clinically meaningful weight gain attributable to second-generation antihistamines in adults has not been conclusively demonstrated. Patients who notice increased hunger or fatigue after starting any antihistamine should document these changes and discuss them with their GP or pharmacist, who can help assess whether a switch to a less sedating option is appropriate.
Reviewing the Evidence: What Clinical Research Shows
The clinical evidence linking antihistamines to weight gain is limited and largely associative. A notable analysis by Ratliff and colleagues, published in the journal Obesity (2010), examined data from the US National Health and Nutrition Examination Survey (NHANES) and found that adults who used prescription antihistamines had a higher mean body mass index (BMI) and waist circumference compared to non-users. Importantly, this was an observational study with significant residual confounding — people with more severe allergic conditions may have lifestyle factors that independently influence weight — and the findings may not directly generalise to UK populations or to over-the-counter antihistamine use.
Some research has examined cetirizine specifically in children. The Early Treatment of the Atopic Child (ETAC) study, a long-term paediatric trial, reported weight outcomes that attracted attention, but the effect sizes were modest and the findings have not been consistently replicated in adult populations. Current UK SmPCs for cetirizine, loratadine, and fexofenadine do not identify weight gain as a common adverse reaction, and this should be the primary reference point for patients and clinicians.
For oral corticosteroids, the evidence is considerably more robust. Weight gain, fluid retention, and increased appetite are well-documented and clearly listed in the prednisolone SmPC approved by the Medicines and Healthcare products Regulatory Agency (MHRA). NICE guidance on conditions requiring corticosteroid therapy consistently highlights the importance of using the lowest effective dose for the shortest possible duration to minimise systemic side effects, including metabolic changes. The NHS also provides clear patient-facing information on corticosteroid side effects and the importance of not stopping treatment abruptly.
In summary:
-
First-generation antihistamines (e.g., chlorphenamine, promethazine) may theoretically influence appetite via sedation and H1 blockade, but weight gain is not an established adverse effect in UK SmPCs
-
Cyproheptadine has the clearest pharmacological link to appetite stimulation and weight gain among antihistamines, but is rarely used for allergy in the UK
-
Oral corticosteroids have the strongest and most consistent evidence for weight gain, well-documented in UK product information
-
Second-generation antihistamines (cetirizine, loratadine, fexofenadine) have a low and uncertain risk; weight gain is not listed as a common adverse effect in their UK SmPCs
-
Intranasal and inhaled corticosteroids at standard doses are unlikely to cause significant weight changes, though high-dose or prolonged use warrants monitoring
Other Factors That Can Influence Weight During Allergy Treatment
It is important not to attribute all weight changes during allergy treatment solely to medication. Several other factors can influence body weight in people managing allergic conditions, and these deserve careful consideration before drawing conclusions.
Allergic conditions themselves can affect lifestyle in ways that indirectly influence weight. For example, poorly controlled allergic rhinitis (hay fever) can cause significant fatigue, disrupted sleep, and reduced motivation for physical activity. Allergic asthma may limit exercise tolerance, particularly during periods of high pollen count or exposure to triggers. These condition-related factors can contribute to weight changes independently of any medication taken.
Diet and seasonal patterns also play a role. Some individuals find that allergy symptoms worsen during spring and summer, leading to periods of reduced outdoor activity and altered eating habits. Stress associated with managing a chronic condition can also influence cortisol levels and appetite regulation. Furthermore, if a patient begins allergy treatment at the same time as other lifestyle changes — such as starting a new job, changing diet, or reducing exercise — it can be difficult to isolate the medication's contribution to any weight change.
It is also worth noting that weight gain is common in the general population and may coincide with starting allergy treatment purely by chance. Other medical causes of weight change — such as thyroid dysfunction or fluid retention from an unrelated cause — should also be considered, and a GP can help assess these if there is any uncertainty.
Keeping a simple diary of weight, appetite, activity levels, and medication use can help both the patient and their GP identify meaningful patterns over time, rather than attributing changes to a single cause prematurely. The NHS provides helpful resources on hay fever self-care and healthy weight management for those who would like additional support.
Talking to Your GP About Allergy Medication Side Effects
If you are concerned that an allergy medication may be contributing to weight gain or changes in appetite, it is entirely appropriate to raise this with your GP or pharmacist. Open communication about side effects is an important part of safe and effective medicines management, and healthcare professionals can help you weigh the benefits of treatment against any potential risks.
When speaking to your GP, it is helpful to bring the following information:
-
The name and dose of the allergy medication you are taking
-
How long you have been taking it
-
Any changes in weight, appetite, or energy levels, including when these began
-
Other medications you are currently taking, as interactions can sometimes contribute to side effects
Your GP may review whether your current medication is the most appropriate option for your allergy profile, or whether a switch to an alternative agent — for example, from cetirizine to loratadine or fexofenadine — might be worth trialling. They may also assess whether any weight change is clinically significant, whether non-medication causes should be investigated, and whether further assessment is warranted.
You should seek prompt medical advice if you experience rapid or unexplained weight gain, significant swelling, or if you are taking oral corticosteroids and notice changes in blood pressure, blood glucose, or mood. These may indicate systemic effects that require monitoring. The NHS advises patients not to stop corticosteroid treatment abruptly without medical guidance, as this can cause adrenal insufficiency — always consult a healthcare professional before making any changes to a prescribed corticosteroid regimen.
If you believe you have experienced a side effect from any medicine, you can report this directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting suspected adverse drug reactions helps the MHRA monitor the safety of medicines used in the UK.
Choosing the Right Allergy Treatment for Your Needs
Selecting the most appropriate allergy treatment involves balancing symptom control with tolerability and individual patient factors, including concerns about weight. NICE Clinical Knowledge Summary (CKS) guidance on allergic rhinitis recommends intranasal corticosteroids as first-line treatment for moderate-to-severe or persistent symptoms, as they are highly effective and have a favourable systemic safety profile compared to oral corticosteroids. For mild or intermittent symptoms, a non-sedating second-generation antihistamine such as loratadine or fexofenadine is often recommended as an appropriate first choice.
For patients who are particularly concerned about weight-related side effects, the following principles may be helpful:
-
Avoid first-generation antihistamines (e.g., chlorphenamine, promethazine) for regular or long-term use where possible, given their sedating properties and theoretical appetite effects
-
Prefer non-sedating second-generation options such as loratadine or fexofenadine, which have a lower propensity for central effects based on their SmPC and BNF sedation profiles
-
Use oral corticosteroids only when clinically necessary and for the shortest effective duration, in line with NICE CKS and MHRA guidance
-
Consider allergen immunotherapy if you have confirmed IgE-mediated allergic sensitisation and symptoms remain poorly controlled despite optimised standard therapy — this treatment is initiated and supervised by specialists in secondary care following appropriate allergy testing, and addresses the underlying immune response rather than simply managing symptoms
It is also worth exploring non-pharmacological strategies alongside medication, such as allergen avoidance measures, nasal saline irrigation, and identifying and reducing exposure to specific triggers. These approaches can reduce the overall medication burden required to control symptoms.
Ultimately, the right treatment is one that effectively manages your allergy symptoms while fitting your broader health goals and lifestyle. A shared decision-making conversation with your GP or an allergy specialist, informed by NICE CKS guidance and BSACI rhinitis management guidelines, will help ensure that your treatment plan is both clinically appropriate and personally suitable.
Frequently Asked Questions
Can taking antihistamines every day cause weight gain over time?
Daily use of second-generation antihistamines such as loratadine or fexofenadine is not associated with weight gain in UK prescribing information, and any effect is considered unlikely and small. First-generation antihistamines like chlorphenamine may theoretically influence appetite through sedation and H1 receptor blockade in the brain, but weight gain is not listed as an established adverse effect in their UK Summaries of Product Characteristics. If you notice changes in weight or appetite during long-term antihistamine use, it is worth discussing this with your GP or pharmacist.
Do allergy medications cause weight gain in children as well as adults?
Some paediatric research, including the ETAC study on cetirizine, has examined weight outcomes in children, but effect sizes were modest and findings have not been consistently replicated. UK SmPCs for cetirizine, loratadine, and fexofenadine do not identify weight gain as a common adverse reaction in children or adults. Parents concerned about weight changes in a child taking allergy medication should speak to their GP, who can assess whether the medication or other factors are responsible.
What is the difference between cetirizine and loratadine when it comes to weight and side effects?
Both cetirizine and loratadine are second-generation antihistamines and neither lists weight gain as a common adverse effect in their UK SmPCs. Cetirizine has a slightly higher reported incidence of somnolence (drowsiness) compared to loratadine and fexofenadine according to SmPC and BNF data, which could theoretically reduce activity levels, though any resulting impact on weight is uncertain. For patients particularly concerned about sedation or weight, loratadine or fexofenadine may be preferable options to discuss with a GP or pharmacist.
Can steroid nasal sprays for hay fever make you put on weight?
Intranasal corticosteroids such as fluticasone propionate nasal spray are absorbed systemically in very small amounts at standard licensed doses and are not typically associated with significant weight gain. At high doses or with prolonged use, some systemic absorption can occur, and clinically relevant effects — though uncommon — cannot be entirely excluded, so patients on long-term high-dose treatment should be monitored as clinically indicated. Oral corticosteroids, by contrast, are well-established causes of weight gain and should be used at the lowest effective dose for the shortest possible duration.
How do I get a prescription for a non-sedating allergy medication if I am worried about weight?
Many second-generation antihistamines, including loratadine and cetirizine, are available over the counter at pharmacies without a prescription, so you can speak to a pharmacist directly for advice on suitable options. If your symptoms are more severe, persistent, or poorly controlled, your GP can prescribe treatments such as intranasal corticosteroids or refer you to an allergy specialist for further assessment. NICE CKS guidance recommends a shared decision-making approach, so raising your concerns about weight-related side effects during the consultation will help your GP tailor the most appropriate treatment plan.
Should I report weight gain as a side effect of my allergy medication?
If you believe you have experienced weight gain or any other unexpected side effect from an allergy medication, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting suspected adverse drug reactions helps the MHRA monitor the real-world safety of medicines used across the UK. You should also discuss the side effect with your GP or pharmacist, who can review whether your current medication remains the most appropriate choice.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
